Key terms
About ALNY
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002 and is headquartered in Cambridge, MA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ALNY news
Yesterday
7:10am ET
Wall Street Analysts Are Bullish on Top Healthcare Picks
Mar 25
6:55am ET
Buy Rating Affirmed for Alnylam Pharmaceuticals on Strong Commercial Business and Expanding CNS Pipeline
Mar 07
7:20am ET
Analysts Are Bullish on Top Healthcare Stocks: DarioHealth (DRIO), United Therapeutics (UTHR)
Mar 06
7:40am ET
Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Alnylam Pharma (ALNY) and IO Biotech (IOBT)
Mar 06
7:25am ET
Buy Rating Affirmed for Alnylam Pharma as Zilebesiran Shows Blockbuster Potential
Mar 06
6:10am ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Humana (HUM), Alnylam Pharma (ALNY) and Spyre Therapeutics (SYRE)
Mar 05
10:15am ET
Buy Rating Affirmed for Alnylam Pharma Amid Positive Clinical Trials and Strategic Collaborations
Mar 05
8:33am ET
Roche, Alnylam report KARDIA-2 study met primary endpoint
Mar 05
7:47am ET
Alnylam reports KARDIA-2 zilebesiran study met primary endpoint of lower SBP
Mar 04
4:43pm ET
Alnylam Pharmaceuticals Finalizes Exit Deal with EVP Franchini
Feb 23
5:20am ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN), Alnylam Pharma (ALNY) and Bausch Health Companies (BHC)
Feb 21
7:31am ET
Analysts Offer Insights on Healthcare Companies: AbCellera Biologics (ABCL), Teladoc (TDOC) and Alnylam Pharma (ALNY)
Feb 20
8:50am ET
Wall Street Analysts Are Bullish on Top Healthcare Picks
Feb 20
7:31am ET
Analysts Offer Insights on Healthcare Companies: Exact Sciences (EXAS), Alnylam Pharma (ALNY) and Catalent (CTLT)
Feb 18
11:55pm ET
Maintaining Hold on Alnylam Pharmaceuticals Amid Clinical and Financial Uncertainties
Feb 17
1:00am ET
Alnylam Pharmaceuticals’ New Regulation Risk – A Cause for Worry?
Feb 16
7:58am ET
Alnylam price target lowered to $161 from $171 at Wells Fargo
Feb 16
7:57am ET
Oppenheimer Remains a Hold on Alnylam Pharma (ALNY)
Feb 16
7:50am ET
Analysts Offer Insights on Healthcare Companies: Healthequity (HQY), Moderna (MRNA) and Alnylam Pharma (ALNY)
Feb 16
7:43am ET
Alnylam price target lowered to $225 from $250 at Chardan
Feb 16
7:37am ET
Piper Sandler Sticks to Their Buy Rating for Alnylam Pharma (ALNY)
Feb 16
7:30am ET
Strategic Trial Adjustments Bolster Alnylam Pharma’s Buy Rating and Anticipate Share Value Surge
Feb 16
7:27am ET
Alnylam price target lowered to $283 from $284 at Canaccord
Feb 16
7:27am ET
Alnylam price target lowered to $283 from $284 at Canaccord
Feb 16
7:14am ET
Intellia Therapeutics price target lowered to $24 from $38 at Baird
Feb 16
7:01am ET
Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), Blueprint Medicines (BPMC) and Medtronic (MDT)
Feb 16
6:57am ET
Barclays Keeps Their Buy Rating on Alnylam Pharma (ALNY)
Feb 16
6:51am ET
Alnylam post-earnings selloff overdone, says Citi
Feb 16
5:22am ET
Maintaining Hold on Alnylam Pharma Amid HELIOS-B Study Uncertainties and Strategic Decision Concerns
Feb 15
8:40pm ET
Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), Travere Therapeutics (TVTX) and Grifols SA (GRFS)
Feb 15
6:25pm ET
Alnylam Pharma (ALNY) was downgraded to a Hold Rating at Goldman Sachs
No recent news articles are available for ALNY
No recent press releases are available for ALNY
ALNY Financials
Key terms
Ad Feedback
ALNY Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ALNY Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range